**Author details**

Angeliki Siamidi1 \* and Yannis Dotsikas2

1 School of Health Sciences, Department of Pharmacy, Division of Pharmaceutical Technology, National and Kapodistrian University of Athens, Athens, Greece

2 School of Health Sciences, Department of Pharmacy, Division of Pharmaceutical Chemistry, National and Kapodistrian University of Athens, Athens, Greece

\*Address all correspondence to: asiamidi@pharm.uoa.gr

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**89**

Per Os *Administered Modified-Release Solid Formulations of Melatonin: A Review of the Latest…*

[7] Vlachou M, Papamichael M, Siamidi A, Fragouli I, Afroudakis PA, Kompogennitaki R, et al. Comparative in vitro controlled release studies on the chronobiotic hormone melatonin from cyclodextrins-containing matrices and cyclodextrin: Melatonin complexes. International Journal of Molecular Sciences. 2017;**18**:1641. DOI: 10.3390/

[8] Vlachou M, Tragou K, Siamidi A, Kikionis S, Chatzianagnostou AL, Mitsopoulos A, et al. Modified in vitro release of the chronobiotic hormone melatonin from matrix tablets based on the marine sulfated polysaccharide ulvan. Journal of Drug Delivery Science and Technology. 2018;**44**:41-48. DOI:

10.1016/j.jddst.2017.11.019

[9] Vlachou M, Stavrou G,

15666180404125519

80813666161006162246

xphs.2018.09.035

Siamidi A, Flitouri S, Ioannidou V, Mavrokordopoulos S. N-acetylserotonin

vs melatonin. In vitro controlled release from hydrophilic matrix tablets. Letters in Drug Design & Discovery. 2018;**15**:347-352. DOI: 10.2174/15701808

[10] Zampakola A, Siamidi A, Pippa N, Demetzos C, Vlachou M. Chronobiotic hormone melatonin: Comparative in vitro release studies from matrix tablets and liposomal formulations. Letters in Drug Design & Discovery. 2017;**14**(4):476-480. DOI: 10.2174/15701

[11] Vlachou M, Kikionis S, Siamidi A, Tragou K, Ioannou E, Roussis V, et al. Modified in vitro release of melatonin loaded in nanofibrous electrospun mats incorporated into monolayered and three-layered tablets. Journal of Pharmaceutical Sciences. 2019;**108**(2):970-976. DOI: 10.1016/j.

[12] Vlachou M, Kikionis S, Siamidi A, Tragou K, Kapoti S, Ioannou E, et al.

ijms18081641

*DOI: http://dx.doi.org/10.5772/intechopen.91158*

[1] Vlachou M, Eikosipentaki A, Xenogiorgis V. Pineal hormone melatonin: Solubilization studies in model aqueous gastrointestinal environments. Current Drug Delivery. 2006;**3**:255-265. DOI: 10.2174/156720106777731073

[2] Vlachou M, Tsiakoulia A,

alginate matrices in aqueous

16307781115449

5226

Eikosipentaki A. Controlled release of the pineal hormone melatonin from hydroxypropylmethylcellulose/sodium

media containing dioctyl sulfosuccinate. Current Drug Discovery Technologies. 2007;**4**:31-38. DOI: 10.2174/1570

[3] Vlachou M, Ioannidou V, Vertzoni M, Tsotinis A, Afroudakis P, Sugden D. Controlled release from solid pharmaceutical formulations of two nalkanoyl-4-methoxybicyclo[4.2.0] octa-1,3,5-trien-7-ethanamines with melatoninergic activity. Letters in Drug Design & Discovery. 2015;**12**:259-262. DOI: 10.2174/157018081166614102400

[4] Zisapel N. Development of a melatonin-based formulation for the treatment of insomnia in the elderly. Drug Development Research.

2000;**50**(3-4):226-234. DOI: 10.1002/1098-2299(200007/08) 50:3/4<226::aid-ddr6>3.0.co;2-s

[5] Lyseng-Williamson KA. Melatonin prolonged release: In the treatment of insomnia in patients aged ≥55 years. Drugs and Aging. 2012;**29**(11):911-923. DOI: 10.1007/s40266-012-0018-z

[6] Vlachou M, Siamidi A. Chapter 9: Melatonin modified release formulations designed for sleep disorders. In: Drăgoi MC, editor. Melatonin - Molecular Biology, Clinical and Pharmaceutical Approaches. Rijeka. ISBN 978-1-78984-505-1: InTechOpen; 2018. DOI: 10.5772/intechopen.78337

**References**

Per Os *Administered Modified-Release Solid Formulations of Melatonin: A Review of the Latest… DOI: http://dx.doi.org/10.5772/intechopen.91158*
